Skip to content
Search

Latest Stories

LloydsPharmacy Clinical Homecare awarded overall ‘Good’ rating by CQC

LloydsPharmacy Clinical Homecare has been awarded ‘Good’ rating in all five domains- safe, effective, caring, responsive and well-led by the Care Quality Commission (CQC).

This is recognition of the huge turnaround the service has made in such a short space of time. The Harlow site was inspected in October 2022.


Established in 1975, LloydsPharmacy Clinical Homecare is one of the most experienced providers of clinical homecare, and delivers care to more than 100,000 patients in the comfort of their home, at work, or in the community – ranging from straightforward delivery of medication to specialist nursing for complex conditions. The provider was credited with having ‘significantly improved’ following negative feedback from the regulators last year.

In particular, it was reported that ‘all staff were committed to continually learning and improving services. They had a good understanding of quality improvement methods and the skills to use them, and leaders encouraged innovation and participation in research’.

Inspectors highlighted LloydsPharmacy Clinical Homecare’s Remote Nurse Training service, which is for patients with long-term conditions. ‘The service has enabled patients, through telephone training, to self-inject their ongoing treatments. It has facilitated greater independence for patients and has reduced the risk of transmission of the COVID-19 virus to a patient group that were considered vulnerable.’

With a success rate of 99%, the training programme was rolled out nationally across 13 different biological therapies. The service was a finalist in the Nursing Times Awards 2020 in the category of Managing Long-term Conditions.

Nick Davis, CEO of LloydsPharmacy Clinical Homecare, said: “The CQC’s report reflects how far we have come in the last year. Every single person who is part of the LloydsPharmacy Clinical Homecare team - from our front-line nurses and healthcare assistants to our senior management team, has worked extremely hard to bring the service back to a standard that we can be proud of, however, we will not rest on our laurels as we strive to do even better each day.

“We are all dedicated to our programme of continuous improvement, and the regulator’s feedback is extremely important to us. The inspectors have also provided valuable guidance on where we can make even more progress, and it will help us reach our goal of being rated outstanding in the near future.”

 

More For You

Omega Pharmacy in Derbyshire Finds New Owner in Just 18 Days

Omega Pharmacy

Christie & Co

Omega Pharmacy in Derbyshire sold in just 18 days

Omega Pharmacy in Derbyshire has found a new owner in less than three weeks after being put on the market.

The pharmacy was previously owned by husband-and-wife duo Manny and Poonam Rai, who decided to sell it after a short period of ownership to focus on their other pharmacy in Coventry, according to Christie & Co.

Keep ReadingShow less
DHSC announces second list of March 2025 price concessions

A price concession only applies for the month it is granted.

Getty Images

March price concessions list released; prescription charge remains unchanged

The Department of Health and Social Care (DHSC) has released a second list of price concessions for March 2025, following ongoing discussions with Community Pharmacy England (CPE) regarding medicine pricing concerns raised by pharmacy owners.

A price concession is introduced when pharmacy contractors are unable to source a drug at or below the reimbursement price set out in the Drug Tariff.

Keep ReadingShow less
AstraZeneca partners with CEPI to develop multi-specific influenza antibody

AstraZeneca-CEPI collaboration aims to increase global access to antibody-based interventions

Getty Images

AstraZeneca secures £33M CEPI funding to develop multi-specific influenza antibody

AstraZeneca has joined forces with the Coalition for Epidemic Preparedness Innovations (CEPI) to advance an innovative antibody technology that could help tackle future infectious disease outbreaks and pandemics swiftly and more affordably.

CEPI will provide up to US$43.5 million (£33.6 million) in funding to support the biopharmaceutical company in evaluating a type of antibody, known as a VHH (Variable Heavy domain of a Heavy chain -only antibody), through preclinical proof-of-concept studies and Phase 1 clinical trials.

Keep ReadingShow less
Community Pharmacy Patient Safety Group announces new vice-chair

Martin Sadr-Kazemi 's appointment follows the passing of Dr. José Moss in January 2025.

Martin Sadr-Kazemi appointed vice-chair of Community Pharmacy Patient Safety Group

The Community Pharmacy Patient Safety Group (CPPSG) has announced the appointment of Martin Sadr-Kazemi as its new vice-chair.

Martin, currently the medication safety officer and deputy superintendent pharmacist at Rowlands Pharmacy, has been an integral member of the CPPSG since its formation a decade ago, actively contributing to various initiatives.

Keep ReadingShow less
"My work benefits all across London," says ambulance pharmacy technician

Mahrukh Jaffar

Pic credit: London Ambulance Service

"My work benefits all across London," says ambulance pharmacy technician

Mahrukh Jaffar will create history when she becomes the first apprentice to become a qualified pharmacy technician through the London Ambulance Service.

Jaffar is just days away from completing her registration with the General Pharmaceutical Council.

Keep ReadingShow less